Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for l root_notes_note in Note (approximate match)

Showing 1501 - 1510 of 1802 results

First page
Previous page
Next page
Next page

Small interfering RNA directed against the RNA-dependent RNA polymerase L of West African Strains of Ebolavirus

YZQ2W5VM8F

Sequence Search

Status:

Other

Class:

NUCLEIC ACID

Poly-L-ornithine (50000 MW)

L2PC3YXG8A

Status:

Other

Class:

POLYMER

Methoxy-poly(ethylene glycol (5000 Da)-block-poly(L-lysine hydrochloride (4900 Da)

6EXU4NP6WT

Status:

Other

Class:

POLYMER

Poly-L-ornithine hydrobromide (50000 MW)

DE3TNF3XYN

Status:

Other

Class:

POLYMER

MECAPEGFILGRASTIM MODIFIED L-METHIONINE

U2IG196TDG

Status:

Other

Class:

POLYMER

N5-((2E)-((2-(((2,3-BIS(.OMEGA.-METHOXYPOLY(OXYETHYLENE))PROPOXY)CARBONYL)AMINO)ETHOXY)IMINO)ETHYL)GLUTAMINE (43000 MW)

7365813625

Status:

Other

Class:

POLYMER

POLY-L-LYSINE (30000-70000 MW)

0A1V8JTU2M

Status:

Possibly Marketed Outside US

Source:

21 CFR 333D

(2022)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aa7416db-4b9e-42a5-8a17-3704231333d3

First approved in 2022

Source:

21 CFR 333D

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aa7416db-4b9e-42a5-8a17-3704231333d3

Class:

POLYMER

POLYLACTIDE, L-

W92NDP347A

Status:

Possibly Marketed Outside US

Source:

NCT00126308: Phase 4 Interventional Terminated HIV-Associated Lipodystrophy

(2005)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT00126308

First approved in 1985

Source:

NDA020263

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e99f47d2-da10-3127-ecb3-e5d942ae6e81

Class:

POLYMER

LITGENPROSTUCEL-L

DU79YU5DEB

Status:

Investigational

Source:

USAN:LITGENPROSTUCEL-L [USAN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/DU79YU5DEB

Class:

STRUCTURALLY DIVERSE

GALGENPROSTUCEL-L

YQA9887BKP

Status:

Investigational

Source:

NCT00577356: Phase 2 Interventional Terminated Prostate Cancer

(2008)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT00577356

Class:

STRUCTURALLY DIVERSE

Nucleic Acid

Small interfering RNA directed against the RNA-dependent RNA polymerase L of West African Strains of Ebolavirus

Structure of Poly-L-ornithine (50000 MW)

Polymer

Poly-L-ornithine (50000 MW)

Structure of Methoxy-poly(ethylene glycol (5000 Da)-block-poly(L-lysine hydrochloride (4900 Da)

Polymer

Methoxy-poly(ethylene glycol (5000 Da)-block-poly(L-lysine hydrochloride (4900 Da)

Structure of Poly-L-ornithine hydrobromide (50000 MW)

Polymer

Poly-L-ornithine hydrobromide (50000 MW)

Structure of MECAPEGFILGRASTIM MODIFIED L-METHIONINE

Polymer

MECAPEGFILGRASTIM MODIFIED L-METHIONINE

Structure of N5-((2E)-((2-(((2,3-BIS(.OMEGA.-METHOXYPOLY(OXYETHYLENE))PROPOXY)CARBONYL)AMINO)ETHOXY)IMINO)ETHYL)GLUTAMINE (43000 MW)

Polymer

N5-((2E)-((2-(((2,3-BIS(.OMEGA.-METHOXYPOLY(OXYETHYLENE))PROPOXY)CARBONYL)AMINO)ETHOXY)IMINO)ETHYL)GLUTAMINE (43000 MW)

Structure of POLY-L-LYSINE (30000-70000 MW)

Polymer

POLY-L-LYSINE (30000-70000 MW)

Structure of POLYLACTIDE, L-

Polymer

POLYLACTIDE, L-

Structurally Diverse

LITGENPROSTUCEL-L

Structurally Diverse

GALGENPROSTUCEL-L

Showing 1501 - 1510 of 1802 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1